My Approach When Prescribing Here's my general framework not a rigid protocol, but a starting point for the conversation: I Tend to Start with Semaglutide When The patient has established cardiovascular disease (because of the SELECT trial data) Insurance covers semaglutide but not tirzepatide The patient has MASH/fatty liver disease Cost is the primary concern and semaglutide is more accessible I Tend to Start with Tirzepatide When Maximum weight loss is the primary goal The patient has type 2 diabetes (tirzepatide shows greater A1C reduction roughly 2.02.5% vs 1.02.0% for semaglutide) The patient has tried semaglutide with insufficient results Insurance covers both options equally Regardless of which medication we choose, I always emphasize that GLP-1 therapy is most effective when combined with nutritional counseling, physical activity, and behavioral support
As, se pueden ver patrones y relaciones que un solo punto de vista dejara pasar
Ive been told we dont metabolize glucose as efficiently as we did in the past as we get older
Retatrutide metabolic benefits Retatrutide has demonstrated even more dramatic metabolic benefits, particularly for liver health and insulin sensitivity
It should be kept in a dry, light-protected environment to prevent degradation
Additionally, hit nomination required statistical significance ( P 0.5 between the mean expression of the sensitive and resistant cohorts